Skip to main content
Clinical Trials/NCT06628414
NCT06628414
Recruiting
Not Applicable

Transcranial Direct Current Stimulation (tDCS) for Tinnitus - Effects of Multiple Treatment Sessions: a Randomised-controlled Pilot Study

University of Nottingham1 site in 1 country40 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
transcranial Direct Current Stimulation
Conditions
Tinnitus
Sponsor
University of Nottingham
Enrollment
40
Locations
1
Primary Endpoint
Proof of concept
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression. Treatment options are limited and do not address tinnitus directly (e.g., reduce its loudness). To do that, we must change brain activity causing tinnitus. Low-dose electrical stimulation, using a technique called transcranial Direct Current Stimulation (tDCS), is a promising approach. The technique is safe and easy to administer. Several small studies have tested tDCS for tinnitus showing some benefits.

To assess whether these benefits will generalise to other patients, we need to conduct a randomised controlled trial - a large, rigorously controlled experiment based on prior agreed procedures. Clinical trials are expensive and time-consuming to run and thus require meticulous pilot work to establish the most effective treatment regimens and the most sensitive measures of treatment outcome. The current study aims to provide such pilot information for a clinical trial of tDCS treatment of tinnitus. Using a total of 40 patients, we will establish how to best to administer tDCS and measure resulting changes in tinnitus perception and associated brain activity.

The current study is a crucial first step towards determining whether or not tDCS can effectively treat tinnitus.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
September 1, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Magdalena Sereda

Assistant Professor

University of Nottingham

Eligibility Criteria

Inclusion Criteria

  • Aged 18 or over
  • Suffering from subjective idiopathic tinnitus
  • Sufficient understanding of English to be able to provide informed consent
  • Able to safely undergo tDCS

Exclusion Criteria

  • Aged under 18
  • Not suffering from tinnitus or suffering from objective tinnitus
  • Insufficient understanding of English to be able to provide informed consent
  • Unable to safely undergo tDCS as assessed by tDCS Safety Questionnaire
  • Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Arms & Interventions

Transcranial Direct Current Stimulation (tDCS)

TDCS will be delivered using a NeuroConn DC Stimulator Plus via two 35cm2 rubber electrodes covered in saline-soaked sponges. The anode electrode will be positioned over EEG 10-20 coordinate F4 and the cathode over F3. The current will be delivered at 2mA for 20 minutes with ramp-up and ramp-down of 10 seconds. Each participant will receive 10 daily stimulation sessions over 2 weeks.

Intervention: transcranial Direct Current Stimulation

Sham

Same as intervention arm but the current will be delivered at 2mA for 30 seconds, after which the stimulation will be discontinued.

Intervention: transcranial Direct Current Stimulation

Outcomes

Primary Outcomes

Proof of concept

Time Frame: Assessed at study end (anticipated as 1 year after study start)

Measured by protocol compliance and attrition

Secondary Outcomes

  • Tinnitus symptom severity(Before first intervention session, after final intervention session and at 3-month follow-up)
  • Tinnitus loudness(Before first intervention session, after each intervention session and at 3-month follow-up (VAS). Before first intervention session and after final intervention session (loudness matching))
  • Depression(Before first intervention session, after final intervention session and at 3-month follow-up)
  • Anxiety(Before first intervention session, after final intervention session and at 3-month follow-up)
  • Treatment satisfaction(After final intervention session and at 3-month follow-up)
  • Adverse effects(After each intervention session (10 sessions over 2 weeks))
  • Electrophysiological brain activity(Before first intervention session and after final intervention session (1st and 10th of 10 sessions over 2 weeks)..)

Study Sites (1)

Loading locations...

Similar Trials